Fingerprint
Dive into the research topics where Beth Chasen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comparison of Three Therapeutic Radiopharmaceutical Infusion Methods for Single and Multivial Applications
Gonzalez, F., Ravizzini, G. C., Santiago, G., Chasen, B. & Hussein, A., 2025, In: Journal of nuclear medicine technology. 53, 3, p. 187-192 6 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Epidemiology of Neuroendocrine Neoplasms in the US
Dasari, A., Wallace, K., Halperin, D. M., Maxwell, J., Kunz, P., Singh, S., Chasen, B. & Yao, J. C., Jun 2025, In: JAMA Network Open. 8, 6, e2515798.Research output: Contribution to journal › Article › peer-review
Open Access39 Link opens in a new tab Scopus citations -
[177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors: Primary analysis of the phase 3 randomized NETTER-2 study
Singh, S., Halperin, D. M., Myrehaug, S., Herrmann, K., Pavel, M., Kunz, P. L., Chasen, B., Capdevila, J., Tafuto, S., Oh, D. Y., Yoo, C., Falk, S., Halfdanarson, T. R., Folitar, I., Zhang, Y., Santoro, P., Aimone, P., de Herder, W. W. & Ferone, D., 2024, In: Journal of Clinical Oncology. 42, 3, LBA588.Research output: Contribution to journal › Article › peer-review
48 Link opens in a new tab Scopus citations -
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
all the NETTER-2 Trial Investigators, Jun 29 2024, In: The Lancet. 403, 10446, p. 2807-2817 11 p.Research output: Contribution to journal › Article › peer-review
249 Link opens in a new tab Scopus citations -
Phase i trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume
Chang, E., Wong, F. C. L., Chasen, B. A., Erwin, W. D., Das, P., Holliday, E. B., Koong, A. C., Ludmir, E. B., Minsky, B. D., Noticewala, S. S., Smith, G. L., Taniguchi, C. M., Rodriguez, M. J., Beddar, S., Martin-Paulpeter, R. M., Niedzielski, J. S., Sawakuchi, G. O., Schueler, E., Perles, L. A. & Xiao, L. & 12 others, , Jun 1 2024, In: JNCI Cancer Spectrum. 8, 3, pkae037.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations